Octave Bioscience Expands Leadership Team with Appointment of Kirk Stockwood Senior Vice President, Commercial

Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson's disease and other neurodegenerative diseases today ...
Hosted on MSN

Hume AI just unveiled Octave — new AI voice generator is eerily human

Hume AI today has unveiled Octave, an innovative text-to-speech (TTS) system that leverages large language model (LLM) technology to generate contextually aware and emotionally nuanced speech. The ...
Business Wire

Octave Bioscience Awarded Valhalla Foundation Grant to Accelerate Development of the First MS Disease Progression Test

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple sclerosis (MS) and other neurodegenerative ...
Business Wire

Octave Bioscience Announces $35M Series C Financing to Accelerate Commercial Momentum

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and other ...

Octave Holdings & Investments and BNW Developments to co-develop Tonino Lamborghini Residences in the UAE

ALPHARETTA, GA, UNITED STATES, December 30, 2025 /EINPresswire.com/ — Octave Holdings & Investments (Octave), a US based privately held real estate investment company that owns, operates, and manages, ...
MobiHealthNews

Hybrid behavioral healthcare company Octave scores $52M

Hybrid value-based behavioral healthcare provider, Octave, announced it had scored $52 million in Series C funding, bringing its total raise to $86 million. Cigna Ventures, Novo Holdings and Avidity ...